Literature DB >> 17971736

Formal synthesis of the ACE inhibitor benazepril x HCl via an asymmetric aza-Michael reaction.

Luo-Ting Yu1, Ji-Ling Huang, Ching-Yao Chang, Teng-Kuei Yang.   

Abstract

A formal enantioselective synthesis of benazepril.HCl (4), an anti- hypertensive drug, is reported. Our synthesis employed an asymmetric aza-Michael addition of L-homophenylalanine ethyl ester (LHPE, 1) to 4-(2-nitrophenyl)-4-oxo- but-2-enoic acid methyl ester (6) as the key step to prepare (2S,3'S)-2-(2-oxo-2,3,4,5- tetrahydro-1H-benzo[b]azepin-3-ylamino)-4-phenylbutyric acid ethyl ester (8), which is the key intermediate leading to benazepril x HCl (4).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17971736      PMCID: PMC6148483          DOI: 10.3390/11080641

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  5 in total

1.  Angiotensin-converting enzyme inhibitors. 9. Novel [[N-(1-carboxy-3-phenylpropyl)amino]acyl]glycine derivatives with diuretic activity.

Authors:  J N Barton; J J Piwinski; J W Skiles; J R Regan; P R Menard; R Desai; F S Golec; L W Reilly; T Goetzen; S N Ueng
Journal:  J Med Chem       Date:  1990-06       Impact factor: 7.446

2.  Synthesis and biological properties of (carboxyalkyl)amino-substituted bicyclic lactam inhibitors of angiotensin converting enzyme.

Authors:  J W Watthey; J L Stanton; M Desai; J E Babiarz; B M Finn
Journal:  J Med Chem       Date:  1985-10       Impact factor: 7.446

3.  A new class of angiotensin-converting enzyme inhibitors.

Authors:  A A Patchett; E Harris; E W Tristram; M J Wyvratt; M T Wu; D Taub; E R Peterson; T J Ikeler; J ten Broeke; L G Payne; D L Ondeyka; E D Thorsett; W J Greenlee; N S Lohr; R D Hoffsommer; H Joshua; W V Ruyle; J W Rothrock; S D Aster; A L Maycock; F M Robinson; R Hirschmann; C S Sweet; E H Ulm; D M Gross; T C Vassil; C A Stone
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

4.  Transition metal salts-catalyzed aza-Michael reactions of enones with carbamates.

Authors:  Shū Kobayashi; Kentaro Kakumoto; Masaharu Sugiura
Journal:  Org Lett       Date:  2002-04-18       Impact factor: 6.005

5.  Synthesis and angiotensin converting enzyme-inhibitory activity of N-[(1S)-1-carboxy-5-(4-piperidyl)pentyl]-L-alanine derivatives.

Authors:  M Kori; K Itoh; Y Inada; T Katoh; Y Sumino; K Nishikawa; H Sugihara
Journal:  Chem Pharm Bull (Tokyo)       Date:  1994-03       Impact factor: 1.645

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.